PL4299135T3 - Pochodne benzizoksazolosulfonamidu - Google Patents

Pochodne benzizoksazolosulfonamidu

Info

Publication number
PL4299135T3
PL4299135T3 PL23203023.9T PL23203023T PL4299135T3 PL 4299135 T3 PL4299135 T3 PL 4299135T3 PL 23203023 T PL23203023 T PL 23203023T PL 4299135 T3 PL4299135 T3 PL 4299135T3
Authority
PL
Poland
Prior art keywords
sulfonamide derivatives
benzisoxazole
benzisoxazole sulfonamide
derivatives
sulfonamide
Prior art date
Application number
PL23203023.9T
Other languages
English (en)
Inventor
Ylva Elisabet Bergman BOZIKIS
Oleg Brodsky
Michelle Ang CAMERINO
Samantha Elizabeth GREASLEY
Robert Louis Hoffman
Robert Arnold Kumpf
Pei-Pei Kung
Paul Francis Richardson
Paul Anthony Stupple
Scott Channing Sutton
Original Assignee
Pfizer Inc.
Ctxt Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc., Ctxt Pty Ltd filed Critical Pfizer Inc.
Publication of PL4299135T3 publication Critical patent/PL4299135T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL23203023.9T 2019-06-18 2020-06-16 Pochodne benzizoksazolosulfonamidu PL4299135T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962863199P 2019-06-18 2019-06-18
US201962953223P 2019-12-24 2019-12-24
US202063025278P 2020-05-15 2020-05-15

Publications (1)

Publication Number Publication Date
PL4299135T3 true PL4299135T3 (pl) 2025-11-12

Family

ID=71738189

Family Applications (2)

Application Number Title Priority Date Filing Date
PL23203023.9T PL4299135T3 (pl) 2019-06-18 2020-06-16 Pochodne benzizoksazolosulfonamidu
PL20743773.2T PL3986890T3 (pl) 2019-06-18 2020-06-16 Pochodne benzizoksazolosulfonamidu

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL20743773.2T PL3986890T3 (pl) 2019-06-18 2020-06-16 Pochodne benzizoksazolosulfonamidu

Country Status (33)

Country Link
US (2) US11492346B2 (pl)
EP (2) EP4299135B1 (pl)
JP (2) JP7352662B2 (pl)
KR (1) KR102823056B1 (pl)
CN (1) CN114364672B (pl)
AU (2) AU2020296361A1 (pl)
BR (1) BR112021025528A2 (pl)
CA (1) CA3143666C (pl)
CL (1) CL2021003372A1 (pl)
CO (1) CO2021017504A2 (pl)
CR (1) CR20210627A (pl)
DK (2) DK4299135T3 (pl)
EC (1) ECSP21091615A (pl)
ES (2) ES2969616T3 (pl)
FI (2) FI4299135T3 (pl)
HR (2) HRP20251225T1 (pl)
HU (1) HUE064683T2 (pl)
IL (1) IL288802B2 (pl)
LT (2) LT3986890T (pl)
MA (1) MA67365B1 (pl)
MD (2) MD3986890T3 (pl)
MX (1) MX2021016085A (pl)
MY (1) MY210207A (pl)
PE (1) PE20220808A1 (pl)
PH (1) PH12021553107A1 (pl)
PL (2) PL4299135T3 (pl)
PT (2) PT4299135T (pl)
RS (2) RS67276B1 (pl)
SI (1) SI3986890T1 (pl)
TW (1) TWI787620B (pl)
UA (1) UA129891C2 (pl)
UY (1) UY38752A (pl)
WO (1) WO2020254946A1 (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201810092D0 (en) * 2018-06-20 2018-08-08 Ctxt Pty Ltd Compounds
CA3141826A1 (en) 2019-05-31 2020-12-03 Ikena Oncology, Inc. Tead inhibitors and uses thereof
PL4299135T3 (pl) 2019-06-18 2025-11-12 Pfizer Inc. Pochodne benzizoksazolosulfonamidu
WO2020254989A1 (en) * 2019-06-19 2020-12-24 Pfizer Inc. Cycloalkyl and heterocycloalkyl benzisoxazole sulfonamide derivatives
US20220024919A1 (en) * 2020-07-15 2022-01-27 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
EP4181920B1 (en) * 2020-07-15 2025-09-10 Pfizer Inc. Kat6 inhibitor and combinations for breast cancer treatment
WO2022187688A1 (en) * 2021-03-05 2022-09-09 Umbra Therapeutics Inc. Covalent kras-binding compounds for therapeutic purposes
WO2022187693A1 (en) * 2021-03-05 2022-09-09 Umbra Therapeutics Inc. Covalent cdk2-binding compounds for therapeutic purposes
AU2022278733A1 (en) * 2021-05-21 2023-11-30 Aurigene Oncology Limited Fused isoxazolyl compounds as kat6a inhibitors
CN118382622A (zh) * 2021-07-05 2024-07-23 杭州英创医药科技有限公司 作为kat6抑制剂的化合物
TW202321263A (zh) 2021-08-10 2023-06-01 大陸商江蘇恆瑞醫藥股份有限公司 磺醯胺衍生物、其製備方法及其在醫藥上的應用
PE20241355A1 (es) * 2021-11-16 2024-07-03 Insilico Medicine Ip Ltd Inhibidores de lisina acetiltransferasa 6a (kat6a) y usos de los mismos
EP4448109A1 (en) * 2021-12-13 2024-10-23 Aurigene Oncology Limited Fused benzoisoxazolyl compounds as kat6a inhibitors
CN116621859A (zh) * 2022-02-18 2023-08-22 山东轩竹医药科技有限公司 三并环类kat6抑制剂
AU2023241822A1 (en) 2022-03-28 2024-09-26 Isosterix, Inc. Inhibitors of the myst family of lysine acetyl transferases
KR20250036135A (ko) * 2022-06-16 2025-03-13 프렐루드 테라퓨틱스 인코포레이티드 유비퀴틴 리가제 결합 모이어티를 갖는 kat6 표적화 화합물
CN119604288A (zh) 2022-07-29 2025-03-11 辉瑞大药厂 用于治疗癌症的包含kat6抑制剂的给药方案
WO2024131772A1 (zh) * 2022-12-20 2024-06-27 杭州中美华东制药有限公司 具有sting抑制作用的含肟化合物及其药物组合物和用途
EP4663635A1 (en) 2023-02-10 2025-12-17 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Crystalline form of sulfonamide derivative and preparation method therefor
AU2024236161A1 (en) 2023-03-16 2025-08-21 Aurigene Oncology Limited Acylsulfonamide kat6a inhibitors
CN120957999A (zh) * 2023-03-27 2025-11-14 北京康辰药业股份有限公司 磺酰胺化合物、其药物组合物和应用
KR20250164842A (ko) 2023-03-30 2025-11-25 화이자 인코포레이티드 Kat6a 억제제에 의한 치료를 위한 예측 바이오마커로서의 kat6a 및 이의 치료 방법
AR132470A1 (es) * 2023-04-19 2025-07-02 Insilico Medicine Ip Ltd Inhibidor de lisina-acetiltransferasa 6a (kat6a), combinaciones y usos del mismo
AU2024262206A1 (en) * 2023-04-25 2025-12-04 Insilico Medicine Ip Limited Crystalline lysine acetyltransferase 6a (kat6a) inhibitor and uses thereof
WO2025007873A1 (zh) * 2023-07-04 2025-01-09 上海齐鲁制药研究中心有限公司 Kat6抑制剂
WO2025036382A1 (zh) * 2023-08-14 2025-02-20 上海复宏汉霖生物医药有限公司 一种磺酰胺类化合物、其制备方法及用途
US20250122182A1 (en) * 2023-09-27 2025-04-17 Isosterix, Inc. MYST Inhibitors
WO2025098417A1 (zh) * 2023-11-08 2025-05-15 再和医药科技（苏州）有限公司 磺酰胺类化合物及其应用
WO2025141469A1 (en) 2023-12-26 2025-07-03 Pfizer Inc. Crystalline form of 2-methoxy-n-{4-methoxy-6-[(1h-pyrazol-1-yl)methyl]-1,2-benzoxazol-3-yl}benzene-1-sulfonamide

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3064003A (en) 1962-11-13 Carboxylic acid derivatives of sub-
US2358031A (en) 1944-09-12 Substituted thiadiazoles
US2525321A (en) 1949-01-07 1950-10-10 American Cyanamid Co Hydroxybenzenesulfonamidoisoxazoles and preparation of same
GB689281A (en) 1950-02-18 1953-03-25 Lunbeck Corp Improvements in or relating to the production of sulphanilamido-thiadiazoles
DE1102745B (de) 1959-06-06 1961-03-23 Boehringer & Soehne Gmbh Verfahren zur Herstellung von 5-Sulfanilamidoisoxazolen
BE617370A (fr) 1961-05-09 1962-11-08 Ciba Geigy Procédé de préparation du 2,5-di-[benzoxazolyl-(2')]-thiofène
US3332942A (en) 1962-11-02 1967-07-25 White Lab Inc Substituted thiadiazoles
JPS498255B1 (pl) 1970-10-08 1974-02-25
US3951967A (en) 1972-03-20 1976-04-20 Merck & Co., Inc. 7-Mercapto(or thio)-benzothiadiazine products
US3960854A (en) 1972-03-20 1976-06-01 Merck & Co., Inc. 7-Mercapto(or thio)-benzothiadiazine products
DE2617809C2 (de) 1976-04-23 1984-09-20 Basf Ag, 6700 Ludwigshafen Verfahren zur Stabilisierung von Chromdioxid-Magnetpigmenten und seine Verwendung
JPS6042794B2 (ja) 1977-09-27 1985-09-25 三共株式会社 イソオキサゾリウム塩，およびその製造方法
US4251664A (en) 1978-05-24 1981-02-17 Henkel Corporation Sulfonamidothiadiazoles, metal complexes thereof, and solutions containing such compounds for use in extraction of metal values
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
JPS603685B2 (ja) 1980-04-15 1985-01-30 日本コロムビア株式会社 絵入りレコ−ド盤の製造方法
GB8427618D0 (en) 1984-11-01 1984-12-05 Shell Int Research Anticoccidial compositions
GB8607683D0 (en) 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
JPS63238006A (ja) 1987-03-26 1988-10-04 Shionogi & Co Ltd イモチ防除剤
US5591761A (en) 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
FI93954C (fi) 1988-11-29 1995-06-26 Warner Lambert Co Menetelmä lääkeaineina käyttökelpoisten 3,5-di-tert-butyyli-4-hydroksifenyylisubstituoitujen 1,2,4- ja 1,3,4-tiadiatsolien sekä oksadiatsolien ja triatsolien valmistamiseksi
JPH03258771A (ja) 1990-03-09 1991-11-19 Tosoh Corp スルホンアミド誘導体、その製法及びそれを有効成分として含有する除草剤
JP2902834B2 (ja) 1991-10-09 1999-06-07 本田技研工業株式会社 自己伸縮型マウント
TW224462B (pl) 1992-02-24 1994-06-01 Squibb & Sons Inc
FR2690160A1 (fr) 1992-04-15 1993-10-22 Rhone Poulenc Rorer Sa Application de dérivés d'acide 2H-1,2,4-benzothiadiazine-1,1-dioxyde-3-carboxylique à la préparation de médicaments, les produits nouveaux, leur préparation et les médicaments les contenant.
NZ247440A (en) 1992-05-06 1995-04-27 Squibb & Sons Inc Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof
CA2121724A1 (en) 1993-04-21 1994-10-22 Toshifumi Watanabe Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction
JP3901229B2 (ja) 1994-05-13 2007-04-04 Ｎｔｎ株式会社 耐熱・潤滑性樹脂組成物
NZ306734A (pl) 1995-04-04 2000-01-28 Texas Biotechnology Corp
US5804585A (en) 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
WO1998021186A1 (en) 1996-11-13 1998-05-22 Cephalon, Inc. Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
US5783705A (en) 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
US6432994B1 (en) 1997-04-28 2002-08-13 Texas Biotechnology Corporation Sulfonamides for treatment of endothelin-mediated disorders
HUP0203954A2 (hu) 1999-09-17 2003-03-28 Millennium Pharmaceuticals, Inc. Xa faktor inhibitorok
WO2001049289A1 (en) 1999-12-31 2001-07-12 Texas Biotechnology Corporation Pharmaceutical and veterinary uses of endothelin antagonists
DK1259485T3 (da) 2000-02-29 2006-04-10 Millennium Pharm Inc Benzamider og beslægtede inhibitorer for faktor Xa
GB0127344D0 (en) 2001-11-14 2002-01-02 Cancer Res Ventures Ltd Assay method
AU2002353717B2 (en) 2001-11-22 2006-08-03 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
JP2003292485A (ja) 2002-04-01 2003-10-15 Yamanouchi Pharmaceut Co Ltd スルホンアミド誘導体
AR043633A1 (es) 2003-03-20 2005-08-03 Schering Corp Ligandos de receptores de canabinoides
AU2004240885A1 (en) 2003-05-21 2004-12-02 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I
WO2004113310A1 (en) 2003-06-25 2004-12-29 Biovitrum Ab Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing
CN1867334A (zh) 2003-07-22 2006-11-22 詹森药业有限公司 作为c－fms激酶抑制剂的喹啉酮衍生物
US7615563B2 (en) 2003-08-08 2009-11-10 Gonzalez Iii Jesus E Compositions useful as inhibitors of voltage-gated sodium channels
KR20060073930A (ko) 2003-08-08 2006-06-29 버텍스 파마슈티칼스 인코포레이티드 통증 치료시 나트륨 또는 칼슘 채널 차단제로서 유용한헤테로아릴아미노설포닐페닐 유도체
US8614318B2 (en) 2003-11-13 2013-12-24 Abbvie Inc. Apoptosis promoters
WO2005049593A2 (en) * 2003-11-13 2005-06-02 Abbott Laboratories N-acylsulfonamide apoptosis promoters
US7642260B2 (en) 2003-11-13 2010-01-05 Abbott Laboratories, Inc. Apoptosis promoters
US7767684B2 (en) 2003-11-13 2010-08-03 Abbott Laboratories Apoptosis promoters
US7973161B2 (en) 2003-11-13 2011-07-05 Abbott Laboratories Apoptosis promoters
JP2008515980A (ja) 2004-10-12 2008-05-15 デコード ジェネティクス イーエイチエフ 閉塞性動脈疾患のためのアリールスルホンアミドぺリ置換二環式化合物
WO2006116615A1 (en) 2005-04-26 2006-11-02 Hypnion, Inc. Benzisoxazole piperazine compounds and methods of use thereof
US7494998B2 (en) 2005-04-26 2009-02-24 Hypnion, Inc. Benzisoxazole piperazine compounds and methods of use thereof
CN101218226A (zh) 2005-05-16 2008-07-09 沃泰克斯药物股份有限公司 作为离子通道调控剂的二环衍生物
DE102005038947A1 (de) 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
BRPI0616800A2 (pt) 2005-10-06 2011-06-28 Sanofi Aventis n-[1,3,4]-tiadiazol-2-il-benzeno sulfonamidas, processos para sua preparação e seu uso como produtos farmacêuticos
RU2008113209A (ru) 2005-10-06 2009-10-10 Санофи-Авентис (Fr) Бициклические {1, 3, 4}тиадиазол-2-иламиды арилсульфоновой кислоты, способы их получения и их использование в качестве фармацевтических средств
DE102005055355A1 (de) 2005-11-21 2007-10-31 Merck Patent Gmbh 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate
CA2633653A1 (en) 2005-12-21 2007-07-05 Vertex Pharmaceuticals Incorporated Heterocyclic derivatives as modulators of ion channels
US8071631B2 (en) 2006-08-16 2011-12-06 The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone Small molecule inhibitors of kynurenine-3-monooxygenase
US20080182845A1 (en) 2006-11-16 2008-07-31 Abbott Laboratories Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection
CA2670026A1 (en) 2006-11-20 2008-05-29 Alantos Pharmaceuticals Holding, Inc. Heterotricyclic metalloprotease inhibitors
US20080194557A1 (en) 2007-01-18 2008-08-14 Joseph Barbosa Methods and compositions for the treatment of pain, inflammation and cancer
EP2173743A2 (en) 2007-07-13 2010-04-14 Icagen, Inc. Sodium channel inhibitors
WO2009058348A1 (en) 2007-11-01 2009-05-07 Sirtris Pharmaceuticals, Inc. Amide derivatives as sirtuin modulators
AU2008345225A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
MX2010006647A (es) 2007-12-26 2010-08-17 Sanofi Aventis Piridil-n-[1,3,4]-tiadiazol-2-il-bencenosulfonamidas ciclicas, procedimientos para su preparacion y su uso como productos farmaceuticos.
US8475505B2 (en) 2008-08-13 2013-07-02 Smed-Ta/Td, Llc Orthopaedic screws
WO2010046780A2 (en) 2008-10-22 2010-04-29 Institut Pasteur Korea Anti viral compounds
ES2533954T3 (es) 2009-04-21 2015-04-16 Nerviano Medical Sciences S.R.L. Derivados de resorcinol como inhibidores de HSP90
UA107360C2 (en) 2009-08-05 2014-12-25 Biogen Idec Inc Bicyclic aryl sphingosine 1-phosphate analogs
KR101529767B1 (ko) 2009-08-07 2015-06-17 추가이 세이야쿠 가부시키가이샤 아미노피라졸 유도체
WO2011082400A2 (en) 2010-01-04 2011-07-07 President And Fellows Of Harvard College Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
CN101747325A (zh) 2010-01-15 2010-06-23 江苏省农药研究所股份有限公司 邻杂环甲酰苯胺类化合物及其合成方法和应用
WO2011085575A1 (zh) 2010-01-15 2011-07-21 江苏省农药研究所股份有限公司 邻杂环甲酰苯胺类化合物及其合成方法和应用
CN101845043A (zh) 2010-01-15 2010-09-29 江苏省农药研究所股份有限公司 邻杂环甲酰苯胺类化合物及其合成方法和应用
US20130109672A1 (en) 2010-04-29 2013-05-02 The United States Of America,As Represented By The Secretary, Department Of Health And Human Service Activators of human pyruvate kinase
TW201210597A (en) 2010-06-09 2012-03-16 Gilead Sciences Inc Inhibitors of hepatitis C virus
WO2012007868A2 (en) 2010-07-12 2012-01-19 Pfizer Limited Chemical compounds
JP5937102B2 (ja) 2010-12-14 2016-06-22 エレクトロフォレティクス リミテッド カゼインキナーゼ１デルタ（ｃｋ１デルタ）阻害剤
WO2012088438A1 (en) 2010-12-22 2012-06-28 Eutropics Pharmaceuticals, Inc. Compositions and methods useful for treating diseases
US9464065B2 (en) 2011-03-24 2016-10-11 The Scripps Research Institute Compounds and methods for inducing chondrogenesis
PL220630B1 (pl) 2012-12-28 2015-11-30 Inst Immunologii I Terapii Doświadczalnej Pan Nowe sulfonamidowe pochodne izoksazolo[5,4-b]pirydyny o aktywności przeciwbakteryjnej, sposób ich wytwarzania oraz nowe zastosowanie 3-aminoizoksazolo[5,4-b]pirydyny
CA2898680A1 (en) 2013-03-15 2014-09-18 Genentech,Inc. Substituted benzoxazoles and methods of use thereof
WO2015102929A1 (en) * 2013-12-30 2015-07-09 Novartis Ag Tricyclic sulfonamide derivatives
US10065945B2 (en) 2014-01-24 2018-09-04 Merck Sharp & Dohme Corp. Isoquinoline derivatives as MGAT2 inhibitors
WO2015163339A1 (ja) 2014-04-23 2015-10-29 田辺三菱製薬株式会社 新規二環性または三環性複素環化合物
JP5900759B2 (ja) 2014-09-25 2016-04-06 Toto株式会社 小便器
CN107278205A (zh) 2015-02-24 2017-10-20 辉瑞大药厂 用作抗癌药的取代的核苷衍生物
GB201510019D0 (en) 2015-06-09 2015-07-22 Cancer Therapeutics Crc Pty Ltd Compounds
WO2017002120A1 (en) 2015-07-02 2017-01-05 Yeda Research And Development Co. Ltd. Selective inhibitors of senescent cells and uses thereof
WO2017098421A1 (en) 2015-12-08 2017-06-15 Glaxosmithkline Intellectual Property Development Limited Benzothiadiazine compounds
CN107098846B (zh) * 2016-02-26 2020-10-09 中国医学科学院药物研究所 N-酰基磺酰胺类FBPase抑制剂、其制备方法、药物组合物及用途
US11970486B2 (en) 2016-10-24 2024-04-30 Janssen Pharmaceutica Nv Compounds and uses thereof
AU2017367086A1 (en) * 2016-11-29 2019-07-18 Epizyme, Inc. Compounds containing a sulfonic group as KAT inhibitors
WO2018226976A1 (en) 2017-06-08 2018-12-13 Kura Oncology, Inc. Methods and compositions for inhibiting the interaction of menin with mll proteins
GB201810092D0 (en) 2018-06-20 2018-08-08 Ctxt Pty Ltd Compounds
PL4299135T3 (pl) 2019-06-18 2025-11-12 Pfizer Inc. Pochodne benzizoksazolosulfonamidu

Also Published As

Publication number Publication date
EP4299135A2 (en) 2024-01-03
IL288802A (en) 2022-02-01
MD3986890T2 (ro) 2024-04-30
US20200399258A1 (en) 2020-12-24
BR112021025528A2 (pt) 2022-04-19
PE20220808A1 (es) 2022-05-20
CN114364672A (zh) 2022-04-15
AU2020296361A1 (en) 2022-01-06
UA129891C2 (uk) 2025-09-03
MD4299135T2 (ro) 2025-11-30
DK3986890T3 (da) 2023-12-18
LT3986890T (lt) 2023-12-11
US11492346B2 (en) 2022-11-08
US20230174522A1 (en) 2023-06-08
AU2023274178A1 (en) 2024-02-15
HUE064683T2 (hu) 2024-04-28
CO2021017504A2 (es) 2022-01-17
RS64931B1 (sr) 2023-12-29
EP4299135A3 (en) 2024-02-28
JP2023175821A (ja) 2023-12-12
CL2021003372A1 (es) 2022-10-07
EP4299135B1 (en) 2025-08-06
LT4299135T (lt) 2025-09-10
IL288802B2 (en) 2025-08-01
CA3143666C (en) 2024-06-11
MD3986890T3 (ro) 2025-07-31
KR20220024671A (ko) 2022-03-03
EP3986890B1 (en) 2023-11-15
FI3986890T3 (fi) 2024-01-15
PT3986890T (pt) 2024-01-17
JP7352662B2 (ja) 2023-09-28
TW202115048A (zh) 2021-04-16
ES2969616T3 (es) 2024-05-21
ES3043899T3 (en) 2025-11-26
CA3143666A1 (en) 2020-12-24
MA67365B1 (fr) 2025-10-31
SI3986890T1 (sl) 2024-03-29
PH12021553107A1 (en) 2022-08-01
EP3986890B9 (en) 2025-04-16
HRP20251225T1 (hr) 2025-12-05
HRP20231501T1 (hr) 2024-03-01
CN114364672B (zh) 2024-09-06
ECSP21091615A (es) 2022-01-31
RS67276B1 (sr) 2025-10-31
MY210207A (en) 2025-09-03
EP3986890A1 (en) 2022-04-27
MX2021016085A (es) 2022-04-20
IL288802B1 (en) 2025-04-01
UY38752A (es) 2021-01-29
US12371425B2 (en) 2025-07-29
PT4299135T (pt) 2025-10-09
WO2020254946A1 (en) 2020-12-24
JP2022537285A (ja) 2022-08-25
PL3986890T3 (pl) 2024-03-11
FI4299135T3 (fi) 2025-10-01
RS64931B9 (sr) 2025-06-30
CR20210627A (es) 2022-02-08
DK4299135T3 (da) 2025-09-08
TWI787620B (zh) 2022-12-21
KR102823056B1 (ko) 2025-06-23

Similar Documents

Publication Publication Date Title
IL288802A (en) Benzisoxazole sulfonamide derivatives
ZA202204675B (en) New methylquinazolinone derivatives
GB201800074D0 (en) Pharmaceutical
GB201800072D0 (en) Pharmaceutical
TWI799429B (zh) 新穎氮喹啉衍生物
HUE070924T2 (hu) 2-Hidroxicikloalkán-1-karbamoil-származékok
PL4077334T3 (pl) Pochodne furoindazolu
IL283990A (en) Modified oxopyridine derivatives
IL290815A (en) History of alpha-d-galactopyranoside
IL286434A (en) Nicoandyl derivatives
EP3290001A4 (en) Vibrator for toothbrush
SG11202012594RA (en) Spirochromane derivatives
GB201819164D0 (en) Artificial-intelligence-assisted surgery
SMT202300420T1 (it) Derivati di solfonilamminobenzammide
EP3243510A4 (en) Sulfonamide pharmaceutical composition
GB201919212D0 (en) Dihydro-cyclopenta-isoquinoline sulfonamides derivatives
PL3770162T3 (pl) Pochodne dihydrochromenu
EP3834079A4 (en) CONFIGURATION FROM MULTIPLE QUESTIONS AND MULTIPLE ANSWERS
GB201919210D0 (en) Dihydro-cyclopenta-isoquinoline derivatives
GB2583973B (en) Tethers
EP3595659A4 (en) AZA DIHYDRO ACRIDONE DERIVATIVES
ZA202200181B (en) 2-hydroxycycloalkane-1-carbamoyl derivatives
HK40058409A (en) Imidozopyrimidine derivatives
HK40042188A (en) N-acetylgalactosamino dendron-clearing agent for dota-pretargeted radioimmunotherapy
GB201806948D0 (en) Derivatives